Suppr超能文献

[中医药调控肿瘤相关巨噬细胞防治肺癌转移的基础研究进展]

[Advances of Fundamental Research on Traditional Chinese Medicine in Regulation of Tumor-associated Macrophages for the Prevention and Treatment of 
Lung Cancer Metastasis].

作者信息

Liu Shihui, Li Jiaxuan, Que Zujun, Yu Pan, Tian Jianhui

机构信息

Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China.

Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China.

出版信息

Zhongguo Fei Ai Za Zhi. 2024 Jul 20;27(7):541-549. doi: 10.3779/j.issn.1009-3419.2024.106.14.

Abstract

Lung cancer is the leading cause of cancer-related deaths worldwide, with metastasis being the primary cause of mortality in lung cancer patients, and its prevention and control efficacy remain limited. In recent years, immunotherapy has emerged as a promising direction for overcoming the bottleneck of metastasis. Macrophages, as essential components of innate immunity, participate in the entire process of tumor initiation and progression. Tumor-associated macrophages (TAMs) represent the most abundant immune population in the tumor microenvironment (TME), displaying both anti-tumor M1-like and pro-tumor M2-like phenotypes. The latter promotes tumor invasion and metastasis, angiogenesis, lymphangiogenesis, immune suppression, and reactivation of dormant disseminated tumor cells (DTCs), thereby facilitating tumor metastasis. In recent years, traditional Chinese medicine (TCM) has shown significant efficacy in inhibiting tumor metastasis and has been extensively validated. It exerts anti-tumor effects by reducing the recruitment of TAMs, inhibiting M2-like polarization, and modulating cytokines and proteins in the TME. This paper reviews the relationship between TAMs and lung cancer metastasis, elucidates the targets and mechanisms of TCM in regulating TAMs to prevent and treat lung cancer metastasis, aiming to provide insights into lung cancer prevention and treatment.
.

摘要

肺癌是全球癌症相关死亡的主要原因,转移是肺癌患者死亡的主要原因,其预防和控制效果仍然有限。近年来,免疫疗法已成为克服转移瓶颈的一个有前景的方向。巨噬细胞作为固有免疫的重要组成部分,参与肿瘤发生和进展的全过程。肿瘤相关巨噬细胞(TAM)是肿瘤微环境(TME)中最丰富的免疫细胞群体,表现出抗肿瘤的M1样和促肿瘤的M2样两种表型。后者促进肿瘤侵袭和转移、血管生成、淋巴管生成、免疫抑制以及休眠播散肿瘤细胞(DTC)的重新激活,从而促进肿瘤转移。近年来,中药在抑制肿瘤转移方面显示出显著疗效,并已得到广泛验证。它通过减少TAM的募集、抑制M2样极化以及调节TME中的细胞因子和蛋白质来发挥抗肿瘤作用。本文综述了TAM与肺癌转移之间的关系,阐明了中药调节TAM预防和治疗肺癌转移的靶点和机制,旨在为肺癌的防治提供思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a5/11331253/6ca1c3ac04dd/img_1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验